News & Exclusives
University Medical Center Hamburg-Eppendorf first in Europe to achieve HIMSS Analytics' top-rating for paperless, digital workflows
LEIPZIG and HAMBURG, GERMANY – (October 26, 2011) – HIMSS Analytics Europe announced today that the University Medical Center Hamburg-Eppendorf (UKE) in Germany has achieved Stage 7 of the Electronic Medical Record Adoption Model (EMRAM). It is the first hospital in Europe to achieve the top rating on HIMSS Analytics’ EMRAM scale, which evaluates the digitisation level of a hospital; stage 7 is awarded for achieving a paperless medical record environment. The University Hospital of Hamburg Eppendorf will be officially recognised for their achievements at the CIO Summit in Geneva, 20-22 November 2011.
“The University Hospital of Hamburg Eppendorf provides a blueprint for transforming healthcare through IT: in just three years it has implemented a hospital-wide IT system based on Soarian® Clinicals and Soarian® Health Archive from Siemens that allows the entire continuum of care to be managed through an electronic patient record. Paper is now superfluous. The benefits are apparent on several levels: thanks to IT systems, patient healthcare can now be delivered more quickly and to a higher standard," says Uwe Buddrus, CEO of HIMSS Analytics Europe.
"We are very excited about this award. The electronic patient record enables us to handle all patient documentation free of the restrictions of a paper-based environment and independently of location. Achieving this level of integration and such a high level of data security represents a milestone in healthcare. At the same time the best possible framework is in place for a future in which telemedicine will play a much greater role," says Dr Peter Gocke, Head of IT at UKE.
"UKE's electronic patient record is unrivalled in Europe. It goes without saying, of course, that as a university hospital we endeavour to make progress through innovation. The fact that UKE has, both nationally and internationally, made such an impression in so many areas, including the hospital IT arena, is outstanding and should make us all proud. Congratulations to the UKE IT team on such a fantastic achievement," said Dr Alexander Kirstein, Commercial Director and member of the UKE executive board.
To be confirmed as EMRAM Stage 7, UKE had to prove — among other factors — that it no longer uses paper charts to deliver and manage patient care, but uses a mixture of discrete data, document images and medical images within its electronic medical record environment. In addition, clinical datawarehouses must be in use to analyse patterns of clinical data to improve quality of care and patient safety. Clinical information can be readily shared via standardised electronic transactions with all entities that are authorised to treat the patient.
In May 2011, UKE received the Stage 6 ranking for closed-loop medication administration and a full complement of PACS, as well as clinical decision support capabilities providing order sets and protocols for various clinical areas.
“We are very proud that our extensive evaluation of hospitals across Europe has quickly led to the identification of the first EMRAM Stage 7 hospital within a year of the introduction of the model,” concludes Uwe Buddrus.
About HIMSS Europe
HIMSS Analytics Europe (HAE) provides healthcare organisations, governments and industry with extensive data resources and services about the adoption and use of healthcare information technology in Europe. HAE’s offerings include comparative hospital IT adoption benchmarking, a European-formulated EMR Adoption Model (EMRAM) scale, and other resources to help hospital directors, IT executives and clinicians compare and measure their progress and how they compare to others. Country-level and application-specific reports also provide insights into major IT adoption trends and applications.
For more information see: www.himssanalytics.eu
Joyce Lofstrom (HIMSS North America)
T: +1 312-915-9237
Christina Roosen (HIMSS Europe)
T: +32 2 793 7633
Armin Scheuer (so2say communications, agency)
T: +49 30 21913610
<< Back to News & Exclusives